Antiviral Therapy 2010 15:775–783 (doi: 10.3851/IMP1613)
Original article Antiretroviral therapy in pregnancy: balancing the risk of preterm delivery with prevention of mother-to-child HIV transmission Claire L Townsend1*, Pat A Tookey1, Marie-Louise Newell1,2, Mario Cortina-Borja1 Medical Research Council Centre of Epidemiology for Child Health, UCL Institute of Child Health, University College London, London, UK Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, South Africa
1 2
*Corresponding author e-mail:
[email protected]
Background: Highly active antiretroviral therapy (HAART) for pregnant HIV-positive women reduces the risk of mother-to-child transmission, but is associated with an increased risk of preterm delivery (
